Related Experiment Videos
In situ hybridization in neuropathology
M N Woodroofe1, M L Cuzner, J W Ironside
1Miriam Marks Department of Neurochemistry, Institute of Neurology, London, UK.
Neuropathology and Applied Neurobiology
|December 1, 1994
Summary
In situ hybridization (ISH) visualizes DNA and RNA in tissues using labeled probes. Advances in non-isotopic labeling and detection enhance sensitivity and expand applications in neuroscience and diagnostics.
Area of Science:
- Molecular Biology
- Genetics
- Neuroscience
Background:
- In situ hybridization (ISH) is a technique for localizing nucleic acids within cells and tissues.
- Traditional ISH used radiolabeled probes, but non-isotopic methods have advanced significantly.
- Increased availability of synthetic nucleic acids has expanded ISH applications.
Purpose of the Study:
- To review the advancements and applications of in situ hybridization (ISH).
- To highlight the benefits of non-isotopic labeling systems in ISH.
- To discuss the diagnostic and research potential of ISH in various disorders.
Main Methods:
- Utilizes specific binding of labeled nucleotide probes to target DNA or RNA.
- Employs non-isotopic labeling systems with enzyme-linked antibody detection.
- Tissue pretreatment and control of probe binding stringency are crucial.
Main Results:
- Non-isotopic ISH offers increased sensitivity and specificity compared to older methods.
- ISH is applicable to both fresh and archival tissue samples.
- The technique is valuable for studying gene expression in CNS disorders and diagnosing viral infections.
Conclusions:
- Non-isotopic ISH is a powerful tool for research and diagnostics.
- Combining ISH with other techniques like immunocytochemistry enhances its potential.
- Further developments, such as in situ PCR, promise even greater sensitivity.